Sitemap - 2026 - The Neuroimmunologist
A not-so-rare yet rarely diagnosed cause of fatigue.
"No Evidence of Disease Activity" Is the Floor, Not the Ceiling.
DMTs are necessary, even transformative. They are just not enough.
Beyond One Drug: What the Tolebrutinib Decision Teaches Us About Progressive MS Trials.
Reading the FDA’s Warning Carefully: Tolebrutinib and the Cost of Uncertainty